Literature DB >> 24050232

A Drosophila approach to thyroid cancer therapeutics.

Tirtha K Das, Ross L Cagan.   

Abstract

Thyroid neoplasias represent among the fastest growing cancers. While surgery has become the treatment of choice for most thyroid tumors, many require chemotherapy. In this review, we examine the contributions of work in the fruit fly Drosophila toward multiple endocrine neoplasia type 2 (MEN2), a Ret-based disease to which recent Drosophila models have proven useful both for understanding disease mechanism as well as helping identify new generation therapeutics.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24050232      PMCID: PMC3779345          DOI: 10.1016/j.ddtec.2012.09.004

Source DB:  PubMed          Journal:  Drug Discov Today Technol        ISSN: 1740-6749


  24 in total

1.  PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras/Raf/MAPK and PI3K/AKT/mTOR pathways.

Authors:  Roberto Gedaly; Paul Angulo; Jonathan Hundley; Michael F Daily; Changguo Chen; Alvaro Koch; B Mark Evers
Journal:  Anticancer Res       Date:  2010-12       Impact factor: 2.480

2.  Csk-deficient boundary cells are eliminated from normal Drosophila epithelia by exclusion, migration, and apoptosis.

Authors:  Marcos Vidal; David E Larson; Ross L Cagan
Journal:  Dev Cell       Date:  2006-01       Impact factor: 12.270

Review 3.  Drosophila as a novel therapeutic discovery tool for thyroid cancer.

Authors:  Tirtha Das; Ross Cagan
Journal:  Thyroid       Date:  2010-07       Impact factor: 6.568

Review 4.  Drosophila cancer models.

Authors:  Vivek A Rudrapatna; Ross L Cagan; Tirtha K Das
Journal:  Dev Dyn       Date:  2011-10-28       Impact factor: 3.780

5.  Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors.

Authors:  T K Das; J Sangodkar; N Negre; G Narla; R L Cagan
Journal:  Oncogene       Date:  2012-08-13       Impact factor: 9.867

6.  Differing Src signaling levels have distinct outcomes in Drosophila.

Authors:  Marcos Vidal; Stephen Warner; Renee Read; Ross L Cagan
Journal:  Cancer Res       Date:  2007-11-01       Impact factor: 12.701

7.  Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer.

Authors:  Arkaitz Carracedo; Li Ma; Julie Teruya-Feldstein; Federico Rojo; Leonardo Salmena; Andrea Alimonti; Ainara Egia; Atsuo T Sasaki; George Thomas; Sara C Kozma; Antonella Papa; Caterina Nardella; Lewis C Cantley; Jose Baselga; Pier Paolo Pandolfi
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

Review 8.  Organ size control by Hippo and TOR pathways.

Authors:  Karen Tumaneng; Ryan C Russell; Kun-Liang Guan
Journal:  Curr Biol       Date:  2012-05-07       Impact factor: 10.834

9.  Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.

Authors:  Qian Huang; Fang Li; Xinjian Liu; Wenrong Li; Wei Shi; Fei-Fei Liu; Brian O'Sullivan; Zhimin He; Yuanlin Peng; Aik-Choon Tan; Ling Zhou; Jingping Shen; Gangwen Han; Xiao-Jing Wang; Jackie Thorburn; Andrew Thorburn; Antonio Jimeno; David Raben; Joel S Bedford; Chuan-Yuan Li
Journal:  Nat Med       Date:  2011-07-03       Impact factor: 53.440

10.  Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.

Authors:  Beth Apsel; Jimmy A Blair; Beatriz Gonzalez; Tamim M Nazif; Morri E Feldman; Brian Aizenstein; Randy Hoffman; Roger L Williams; Kevan M Shokat; Zachary A Knight
Journal:  Nat Chem Biol       Date:  2008-10-12       Impact factor: 15.040

View more
  10 in total

Review 1.  Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.

Authors:  Stephen J Marx; David Goltzman
Journal:  J Bone Miner Res       Date:  2018-12-10       Impact factor: 6.741

Review 2.  Aging and the clock: Perspective from flies to humans.

Authors:  Aliza K De Nobrega; Lisa C Lyons
Journal:  Eur J Neurosci       Date:  2018-10-30       Impact factor: 3.386

3.  The Drosophila Ret gene functions in the stomatogastric nervous system with the Maverick TGFβ ligand and the Gfrl co-receptor.

Authors:  Logan Myers; Hiran Perera; Michael G Alvarado; Thomas Kidd
Journal:  Development       Date:  2018-02-02       Impact factor: 6.868

Review 4.  Drug Discovery in Fish, Flies, and Worms.

Authors:  Kevin Strange
Journal:  ILAR J       Date:  2016-12

Review 5.  Cell motility in cancer invasion and metastasis: insights from simple model organisms.

Authors:  Christina H Stuelten; Carole A Parent; Denise J Montell
Journal:  Nat Rev Cancer       Date:  2018-03-16       Impact factor: 60.716

Review 6.  The Drosophila Accessory Gland as a Model for Prostate Cancer and Other Pathologies.

Authors:  C Wilson; A Leiblich; D C I Goberdhan; F Hamdy
Journal:  Curr Top Dev Biol       Date:  2016-07-25       Impact factor: 4.897

Review 7.  Evolving toward a human-cell based and multiscale approach to drug discovery for CNS disorders.

Authors:  Eric E Schadt; Sean Buchanan; Kristen J Brennand; Kalpana M Merchant
Journal:  Front Pharmacol       Date:  2014-12-02       Impact factor: 5.810

8.  Modeling human diseases: an education in interactions and interdisciplinary approaches.

Authors:  Leonard Zon
Journal:  Dis Model Mech       Date:  2016-06-01       Impact factor: 5.758

Review 9.  Drosophila as a toolkit to tackle cancer and its metabolism.

Authors:  Hui Jiang; Taku Kimura; Han Hai; Ryodai Yamamura; Masahiro Sonoshita
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

Review 10.  Modelling Cooperative Tumorigenesis in Drosophila.

Authors:  Helena E Richardson; Marta Portela
Journal:  Biomed Res Int       Date:  2018-03-06       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.